In an observational retrospective study, researchers evaluated annualized relapse rate 12 months pre-fertility treatment and 3 months post-fertility treatment and identified factors related with increased relapse risk.
Research findings from Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2023 provide updates on MS diagnosis and treatment.
Research findings support the use of vitamin D supplementation to help slow cognitive decline in Alzheimer dementia and reduce Parkinson disease symptom severity.
What is the link between multiple sclerosis and depression, and how can you help patients with their mental health?
Presenting at CMSC 2022, researchers assessed the risk for reproductive and embryofetal toxicity in women exposed to ponesimod during pregnancy.
The Cionic Neural Sleeve is the first product to combine movement analysis and augmentation into a wearable garment.
Risk for MS increased 32-fold following EBV infection, but not following infection with other viruses, including cytomegalovirus.
Investigators sought to better understand the pathological correlates associated with increased serum GFAP in the normal appearing white matter of patients with multiple sclerosis.
This review provides a concise overview of the types, pathogenesis, diagnostic criteria, differential diagnosis, and treatment of multiple sclerosis.
Three agents were recently FDA approved for NMOSD in adults who are AQP4 antibody positive: eculizumab, inebilizumab-cdon, and satralizumab-mwge
